Immulox, UPC 1 82863 000064 6. Immune Balance Polypeptide Supplement with Naturally Occuring Bioactive Peptides. 5.07 oz (150 ml)

Aps BioGroup, INC recalled Immulox, UPC 1 82863 000064 6. Immune Balance Polypeptide Supplement with Naturally Occuring Bioactive Peptides. in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on May 15, 2019.

The FDA-published reason for this recall is: "The recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia."

Distribution was broad: the FDA record describes it as "Nationwide and Switzerland. No military/govt/VA consignees," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Phoenix, AZ. The recall covers 7,132 Total Units of product. The FDA has Terminated this recall (first reported Jun 26, 2019), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.